Can biotech deliver new antibiotics?
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 8 (5), 498-503
- https://doi.org/10.1016/j.mib.2005.08.007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antibiotics: Where did we go wrong?Drug Discovery Today, 2005
- Predicting the evolution of antibiotic resistance genesNature Reviews Microbiology, 2004
- Why is big Pharma getting out of antibacterial drug discovery?Current Opinion in Microbiology, 2003
- Where will new antibiotics come from?Nature Reviews Microbiology, 2003
- The abandonment of antibacterials: why and wherefore?Current Opinion in Pharmacology, 2003
- Antibiotic resistance in the intensive care unit settingExpert Review of Anti-infective Therapy, 2003
- Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures.Expert Review of Anti-infective Therapy, 2003
- The threat from the pink cornerAnnals of Medicine, 2003
- Bacterial resistance—the clinical challengeClinical Microbiology & Infection, 2002
- Perspective Threats to Global Health and Survival: The Growing Crises of Tropical Infectious Diseases‐Our “Unfinished Agenda”Clinical Infectious Diseases, 1999